If you have any problems related to the accessibility of any content (or if you want to request that a specific publication be accessible), please contact (email@example.com). We will work to respond to each request in as timely a manner as possible.
Now showing items 1-1 of 1
Synthesis of Novel CADA Analog Prodrugs and Ring-Size Variants Designed to Act as anti-HIV Agents via Down-Modulation of the CD4 Receptor
Cyclotriazadisulfonamide (CADA) inhibits HIV replication by selectively down-modulating expression of the CD4 receptor protein on host cells. Current studies are aimed at developing a prodrug approach involving various ...